- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07934368
The Effect of Virtual Reality Distraction on Anxiety, Pain, and Satisfaction in Patients Undergoing Cardiac Catheterization in Palestine (VR during Cath)
The Effect of Virtual Reality Distraction on Anxiety, Pain, and Satisfaction in Patients Undergoing Cardiac Catheterization in Palestine: A Randomized Controlled Clinical Trial
This randomized controlled trial evaluated the effect of immersive virtual reality (VR) distraction on procedural anxiety, pain, and patient satisfaction among adult patients undergoing cardiac catheterization.
Patients undergoing cardiac catheterization often experience significant anxiety and pain, which can negatively affect procedural outcomes and overall patient satisfaction. Immersive virtual reality has emerged as a promising non-pharmacological nursing intervention to mitigate procedural distress.
Participants were randomized into two groups: an intervention group receiving immersive VR distraction prior to and during the catheterization procedure, and a control group receiving standard nursing care. Procedural anxiety, pain intensity, and overall satisfaction were assessed using validated measurement instruments to determine the efficacy of the intervention.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Background:
Cardiac catheterization is a widely performed invasive diagnostic and therapeutic procedure. Despite its clinical safety, patients frequently experience high levels of pre-procedural and intra-procedural anxiety and physical pain, which can induce hemodynamic instability and reduce patient satisfaction.
Study Design and Setting:
This study was conducted as a single-center, parallel-group, randomized controlled clinical trial at An-Najah National University Hospital in Nablus, Palestine.
Methods & Procedure:
A total of 92 eligible adult patients scheduled for cardiac catheterization were enrolled and randomly allocated (1:1) to either:
- VR Intervention Group: Received immersive virtual reality distraction (using a head-mounted display presenting relaxing virtual environments) delivered before and during the catheterization procedure alongside standard care.
- Control Group: Received standard peri-procedural nursing care.
Outcomes & Measurements:
Primary Outcome: Procedural anxiety measured before and after the intervention using a validated anxiety scale. Procedural pain intensity measured via the Numeric Rating Scale (NRS) and overall patient satisfaction assessed post-procedure.
Ethical Considerations:
Ethical approval was granted by the Institutional Review Board at Arab American University (R-2026/A/82/N). All participants provided written informed consent prior to enrollment.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Nablus
-
Nablus, Nablus, Palestinska territorier, P400
- An-Najah National University Hospital (NNUH)
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Adults ≥ 18 years undergoing elective diagnostic or interventional cardiac catheterization.
- Able to understand and provide consent in Arabic.
- No contraindications to VR (e.g., severe motion sickness, uncontrolled epilepsy).
Exclusion Criteria:
- Emergency cardiac catheterization.
- Cognitive impairments that might obstruct participation.
- Severe visual or auditory impairments incompatible with VR use.
- History of significant adverse reactions to VR.
- Previous participation in a VR intervention study related to cardiac procedures
- A documented history of an anxiety disorder
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Control Group
Patients in this group received standard peri-procedural nursing and medical care before the cardiac catheterization procedure without virtual reality distraction. |
Standard clinical and nursing care during cardiac catheterization without virtual reality intervention. |
|
Experimentell: VR Intervention Group
VR Intervention Group patients in this group received immersive virtual reality (VR) distraction using a head-mounted display presenting relaxing virtual environments before the cardiac catheterization procedure, alongside standard care. |
Experimental VR Intervention Group Patients in this group received immersive virtual reality (VR) distraction using a head-mounted display presenting relaxing virtual environments before the cardiac catheterization procedure, alongside standard care. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
State Anxiety Measured by the State-Trait Anxiety Inventory, State Anxiety Subscale (Form Y-1)
Tidsram: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
|
State anxiety was measured using the Arabic version of the State-Trait Anxiety Inventory, State Anxiety Subscale (Form Y-1), a 20-item self-report questionnaire. Total scores range from 20 (minimum) to 80 (maximum); higher scores indicate greater anxiety (a worse outcome). The between-group difference in change from baseline was assessed at the pre-procedural assessment (immediately after the 15-minute virtual reality session in the intervention group, or after an equivalent routine waiting period in the control group) and at the post-procedural assessment. |
Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
|
|
Pain Intensity Measured by the Numeric Rating Scale
Tidsram: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
|
Pain intensity was measured using an 11-point Numeric Rating Scale. Scores range from 0 (no pain, minimum) to 10 (worst possible pain, maximum); higher scores indicate greater pain intensity (a worse outcome). |
Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
|
|
Satisfaction With Nursing Care Measured by the Patient Satisfaction With Nursing Care Quality Questionnaire
Tidsram: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
|
Satisfaction with nursing care was measured using the Arabic version of the Patient Satisfaction With Nursing Care Quality Questionnaire. Each of the 17 items is rated from 1 (poor) to 5 (excellent), and the score is the mean of the items, ranging from 1 (minimum) to 5 (maximum); higher scores indicate greater satisfaction (a better outcome). |
Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- VR-Cardiac-2026
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Individual participant data will not be publicly shared to protect patient privacy and confidentiality in accordance with the institutional review board approvals and informed consent agreements.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .